与神经髓炎光学谱系障碍中疾病复发率相关的因素
Hai-Yun Li1, Cai-San Cui2, Hui-Min Yang3
1Department of Geriatric Medicine, Qilu Hospital of Shandong University, Jinan, China.
The International journal of neuroscience
|July 17, 2023
概括
神经omyelitis optica光谱障碍 (NMOSD) 的复发受到初始残疾,病变位置和治疗等因素的影响. 识别这些预测因素有助于管理NMOSD并预防复发.
科学领域:
- 神经免疫学 神经免疫学
- 脱线性疾病 脱线性疾病
- 神经学 神经学
背景情况:
- 神经脊髓炎光学谱系障碍 (NMOSD) 是一种严重的自身免疫性脱髓化疾病.
- 高复发率和残疾强调需要了解复发因素.
研究的目的:
- 确定影响NMOSD复发的关键因素.
- 为改善临床治疗策略提供基础.
主要方法:
- 根据2015年的诊断标准,对259名NMOSD患者进行了回顾性分析.
- 收集临床,CSF,血清,MRI,治疗和预后数据.
- 多变量后勤回归用于确定复发预测因子.
主要成果:
- 整体复发率为36.67%.
- 在复发和非复发组之间观察到EDSS得分,病变位置,血清肌素和治疗策略的显著差异.
- 确定了NMOSD在两年内复发的五种预测因素:初始EDSS分数,横向骨髓炎,大脑/脑干病变,血清肌素和特定治疗方法 (Rituximab/免疫抑制剂).
结论:
- 在NMOSD中,复发是多因素的.
- 识别和管理初始残疾和病变特征等预测因素对于预防复发至关重要.
- 基于这些因素的有针对性的干预措施可以改善患者的预后,减少长期残疾.
相关概念视频
Psychological and Sociocultural Causes of Schizophrenia
142
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
142
Myasthenia Gravis: Overview and Treatment
1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K
Myasthenia Gravis: Diagnostic Tests
1.0K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.0K


